Lanzetta, Paolo http://orcid.org/0000-0003-3746-141X
Funding for this research was provided by:
Università degli Studi di Udine
Article History
Received: 11 August 2021
Revised: 5 October 2021
Accepted: 6 October 2021
First Online: 20 October 2021
Change Date: 21 February 2022
Change Type: Update
Change Details: Open access funding provided by Università degli Studi di Udine within the CRUI-CARE Agreement has been added as funding statement.
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: PL is a consultant to Aerie, Apellis, Bayer, Biogen, Centervue, Novartis, and Roche.